Celestica Inc. (NYSE:CLS) shares are up on Monday as the company announced a strategic collaboration with Advanced Micro Devices, Inc. (NASDAQ:AMD) to advance the “Helios” rack-scale AI platform.
This news comes as the broader market is experiencing gains, with the Nasdaq up 1.25% and the Technology sector gaining 1.74%, indicating a positive sentiment in the market.
Details
Celestica will undertake the research and development, design, and manufacturing of scale-up networking switches for AMD’s “Helios” architecture, which is based on the Open Compute Project standards.
This collaboration aims to enhance deployments of AI solutions across various sectors, including cloud and enterprise environments, addressing a growing demand for efficient AI infrastructure.
The company expects the “Helios” platform to optimize performance for large-scale AI clusters, utilizing advanced networking silicon to connect AMD’s next-generation GPUs.
This initiative reflects a significant step in Celestica’s strategy to leverage its engineering and manufacturing capabilities in the rapidly evolving AI market.
Technical Analysis
The stock is currently trading 0.1% above its 20-day simple moving average (SMA) but is 8.8% below its 100-day SMA, indicating some short-term strength while facing longer-term challenges. Over the past 12 months, shares have surged 201.42%, and they are currently positioned closer to their 52-week highs than lows.
The RSI is at 42.84, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD shows a value of -9.1232, below its signal line at -8.7642, indicating bearish pressure on the stock.
The combination of neutral RSI and bearish MACD suggests mixed momentum.
- Key Resistance: $307.00
- Key Support: $266.50
Analyst Outlook
Analyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $288.44. Recent analyst moves include:
- CIBC: Outperformer (Lowers Target to $360.00) (Mar. 11)
- Citigroup: Buy (Lowers Target to $338.00) (Jan. 30)
- Barclays: Overweight (Raises Target to $391.00) (Jan. 30)
Benzinga Edge Rankings
Below is the Benzinga Edge scorecard for Celestica, highlighting its strengths and weaknesses compared to the broader market:
- Value Rank: 24.8 — The stock is trading at a steep premium relative to peers.
- Growth Rank: 91.27 — Indicates strong growth potential.
- Quality Rank: 98.42 — Reflects a healthy balance sheet and operational efficiency.
- Momentum Rank: 95.17 — The stock is outperforming the broader market.
The Verdict: Celestica’s Benzinga Edge signal reveals a strong growth trajectory with excellent quality metrics. While the momentum score indicates the stock is performing well, the low value rank suggests it may be trading at a premium, warranting caution for potential investors.
CLS Stock Price Activity: Celestica shares were up 4.71% at $275.88 at the time of publication on Monday, according to Benzinga Pro data.
Photo via Shutterstock
Recent Comments